SCIEX Acquires Intabio
January 21, 2021
SCIEX has acquired Intabio, a privately held developer of the Blaze system for imaged cIEF–MS biotherapeutic analysis. The acquisition brings Intabio's imaged cIEF-MS technology and team (remaining in Fremont, California) into SCIEX to accelerate biotherapeutic characterization and increase instrument workflow efficiency; financial terms were not disclosed.
- Buyers
- SCIEX
- Targets
- Intabio, Inc.
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
BBI Solutions Acquires IBEX Technologies Inc.
April 8, 2024
Biotechnology
BBI Solutions OEM Limited has acquired IBEX Technologies Inc., a Montreal-based developer and manufacturer of high-precision enzymes and diagnostic solutions, with the transaction closing on April 8, 2024. The acquisition expands BBI's recombinant protein and enzyme capabilities to better serve in-vitro diagnostics (IVD) manufacturers and brings IBEX's staff and contract-manufacturing capabilities into BBI's global operations.
-
Calibre Scientific Acquires MoBiTec GmbH
January 15, 2024
Biotechnology
Calibre Scientific has acquired MoBiTec GmbH, a German supplier of consumables and services for molecular and cell biology. MoBiTec will be integrated into BIOZOL Diagnostica GmbH (a Calibre subsidiary) to broaden BIOZOL's product range and strengthen the group's capabilities and sales presence in the DACH research, diagnostics, and pharmaceutical markets.
-
Optibrium Acquires BioPharmics LLC
August 31, 2023
Software
Optibrium, a Cambridge-based developer of software and AI solutions for small-molecule drug discovery, has acquired BioPharmics LLC to expand its 3D ligand- and structure-based drug design and visualisation capabilities. The acquisition brings BioPharmics' algorithms and products (including ForceGen, Surflex-Dock, eSim and QuanSA) and its founding scientists into Optibrium's StarDrop platform to strengthen 3D modelling, docking and binding-affinity prediction functionality.
-
Leica Biosystems Acquires Cell IDx
November 8, 2022
Biotechnology
Leica Biosystems has acquired Cell IDx, a San Diego-based leader in multiplexed tissue profiling, integrating Cell IDx's UltraPlex multiplex IHC technology with Leica's BOND RX automation to expand translational research and multiplexing capabilities. The deal advances Leica's research-focused staining and imaging portfolio and brings scale-up and medical/scientific affairs support for Cell IDx customers.
-
PerkinElmer Acquires Cisbio Bioassays from Abénex
April 26, 2019
Biotechnology
PerkinElmer has acquired Cisbio Bioassays from Abénex (with Cisbio management supporting the sale). Cisbio, headquartered in Codolet, France, is a manufacturer of HTRF assay kits, reagents and custom assay services with more than 200 employees; the acquisition expands PerkinElmer's life‑sciences reagent and screening technology portfolio.
-
Abenex Acquires Cisbio Bioassays from Argos Soditic
June 16, 2016
Biotechnology
French private equity firm Abenex has acquired Cisbio Bioassays from seller Argos Soditic. Abenex will partner with the biotech to support its organic and external growth strategy across pharmaceutical research and in vitro diagnostics; Cisbio has ~210 employees and generates over 85% of revenue outside France.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.